Avantor, Inc. announced in connection with its planned business segment realignment, on December 1, 2023, the company informed each of Sheri Lewis, the company's Executive Vice President, Global Supply Chain, and Frederic Vanderhaegen, the company's Executive Vice President, Europe, that each would depart from the company in 2024 after supporting the company's transition to its new operating model. Randy Stone will serve as Executive Vice President of Laboratory Solutions. Mr. Stone currently serves as Executive Vice President, Proprietary Research Products and Materials.

Prior to joining Avantor, Mr. Stone had a 16-year tenure at DuPont in the Americas and Asia Pacific, most recently as President of the Mobility and Materials business. Benoit Gourdier will serve as Executive Vice President of Bioscience Production. Mr. Gourdier currently serves as Executive Vice President, Biopharma Production and recently joined Avantor following a 25-year career driving growth and leading commercial organizations, most recently as Senior Vice President and General Manager, BioReliance Contract Testing Services at Millipore Sigma.

Avantor's sales organization in the Americas and Europe and global strategic partners organization will be realigned under Jim Bramwell in his new role as Executive Vice President, Sales. Mr. Bramwell currently serves as Executive Vice President, Americas and has been with the company for 30 years in a variety of commercial leadership roles. Changes to Avantor's operating model and organizational structure, including Mr. Stone's, Mr. Gourdier's, and Mr. Bramwell's new leadership roles, will become effective January 1, 2024.